Aktie A3DWPN TALPHERA, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Talphera, Inc.

Aktien

A3DWPN

US00444T2096

TLPH

Realtime-Estimate Cboe BZX
Andere Börsenplätze
 21:06:55 05.07.2024 		% 5 Tage % 1. Jan.
0,919 USD -0,11 % Intraday Chart für Talphera, Inc. +4,61 % +26,67 %
14.05. Talphera, Inc. meldet Ergebnis für das erste Quartal bis zum 31. März 2024 CI
14.05. Transcript : Talphera, Inc., Q1 2024 Earnings Call, May 14, 2024

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Talphera Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Talphera to Participate at A.G.P. Virtual Healthcare Conference
Talphera, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Talphera: Q1 Earnings Snapshot
Talphera, Inc. Appoints Dr. Shakil Aslam as Chief Development Officer, Effective May 20, 2024
Talphera: Q4 Earnings Snapshot
Talphera, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Talphera, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
Talphera, Inc. Announces Management Changes
Talphera Announces Reduction in Size of its Board of Directors from Ten to Seven Members
Talphera, Inc. Appoints Abhinav Jain to Serve as a Class II Director
XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA Acquisition
XOMA Acquires Interest in Pain Management Medication Dsuvia for $8 Million
Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
XOMA Corporation acquired DSUVIA® of Talphera, Inc. for $8 million.
Talphera, Inc. announced that it expects to receive $16 million in funding from Nantahala Capital Management, LLC, Rosalind Advisors, Inc.
AcelRx Pharmaceuticals, Inc. will Change its Ticker to TLPH from ACRX
AcelRx Announces Rebranding With Name Change to Talphera, Inc.
Talphera Expects to Initiate the Registrational Study of Niyad
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DWPN Aktie
  4. Nachrichten Talphera, Inc.
  5. Andere Sprachen